Anna F Farago
6PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jun 09, 2025
Defining Non-small Cell Lung Cancer Tumor Microenvironment Changes at Primary and Acquired Immune Checkpoint Inhibitor Resistance Using Clinical and Real-World Data.Lang Ho Lee, Xin Xu, Thanos Mourikis
|Oct 29, 2024
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes.Catherine B Meador, Subba R Digumarthy, Beow Y Yeap
|Feb 22, 2024
Acquired Cross-Resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC Paralogs.Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim
|Jul 10, 2023
Acquired Cross-resistance in Small Cell Lung Cancer due to Extrachromosomal DNA Amplification of MYC paralogs.Shreoshi Pal Choudhuri, Luc Girard, Jun Yi Stanley Lim
|Mar 01, 2021
Updated Integrated Analysis of the Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.Rafal Dziadziuszko, Matthew G Krebs, Filippo De Braud
|Mar 05, 2020
Larotrectinib, a selective tropomyosin receptor kinase inhibitor for adult and pediatric tropomyosin receptor kinase fusion cancers.Anna F Farago, George D Demetri
Pageof 1
Frequent Collaborators
3 joint publications
Catherine B Meador
2 joint publications
Collin Gilbreath
2 joint publications
Seth Hamilton
2 joint publications
Jun Zhong
2 joint publications
Edmond Wong
2 joint publications
Shreoshi Pal Choudhuri
2 joint publications
Luc Girard
2 joint publications
Jun Yi Stanley Lim
2 joint publications
Jillian F Wise
2 joint publications
Di Yang
